Showing results (261-270 of 396) with videos related to
Sort By:
Pageof 40
Journal of Neuro-Oncology|June 18, 2010
Up-front temozolomide in elderly patients with anaplastic oligodendroglioma and oligoastrocytomaFrançois Ducray, Monica Sierra del Rio, Catherine Carpentier, et al.Cancer Cell International|February 10, 2010
ASPM-associated stem cell proliferation is involved in malignant progression of gliomas and constitutes an attractive therapeutic targetSandra-Nadia Ngwabyt Bikeye, Carole Colin, Yannick Marie, et al.Brain Pathology (Zurich, Switzerland)|September 28, 2019
Ki-67 and MCM6 labeling indices are correlated with overall survival in anaplastic oligodendroglioma, IDH1-mutant and 1p/19q-codeleted: a multicenter study from the French POLA networkCelso Pouget, Sébastien Hergalant, Emilie Lardenois, et al.Molecular Neurobiology|February 3, 2017
Melanocortin Receptor-4 Gene Polymorphisms in Glioblastoma Patients Treated with Concomitant Radio-ChemotherapyFrancesco Pasqualetti, Paola Orlandi, Vittorio Simeon, et al.NMR in Biomedicine|August 7, 2026
Diagnostic Accuracy of APTw and NOEw MRI Metrics for IDH Mutation and 1p/19q Codeletion Prediction in GliomasCapucine Cadin, Stefano Casagranda, François Xavier Lejeune, et al.The Journal of Experimental Medicine|July 1, 2022
Conserved meningeal lymphatic drainage circuits in mice and humansLaurent Jacob, Jose de Brito Neto, Stephanie Lenck, et al.Brain Pathology (Zurich, Switzerland)|May 18, 2012
KIAA1549-BRAF fusions and IDH mutations can coexist in diffuse gliomas of adultsManuela Badiali, Vincent Gleize, Sophie Paris, et al.Cancers|April 3, 2021
An AI-Powered Blood Test to Detect Cancer Using NanoDSFPhilipp O Tsvetkov, Rémi Eyraud, Stéphane Ayache, et al.Neuro-Oncology|January 31, 2006
Phase 1 trial of a CpG oligodeoxynucleotide for patients with recurrent glioblastomaAlexandre Carpentier, Florence Laigle-Donadey, Sarah Zohar, et al.Journal of Neuro-Oncology|June 15, 2019
Temporary blood-brain barrier disruption by low intensity pulsed ultrasound increases carboplatin delivery and efficacy in preclinical models of glioblastomaAntonin Dréan, Nolwenn Lemaire, Guillaume Bouchoux, et al.Pageof 40